We tested the role of IL-25 by administering recombinant IL-25 (rIL-25) to mice during amebic colitis and discovered that IL-25 protected against amebic colitis and that this protection was eosinophil dependent and acted in part by suppressing TNF-α. This evidence concerns the gene TNF and amebic dysentery.